Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$23.16 USD
+0.12 (0.52%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $23.63 +0.47 (2.03%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Bicycle Therapeutics PLC Sponsored ADR [BCYC]
Reports for Purchase
Showing records 61 - 80 ( 101 total )
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
1Q21: One More Bicycle to Enter the Race in 2021. PT to $35.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Clinical Updates in 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
4Q20 - Bicycles Work. The Milestones Ahead are Critical
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Proof-of-Concept Delivered for the Second-Generation BTC; Higher $31 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Bicycles Provide Versatility That Biologics Lack; Assuming Coverage With a Buy and $28 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2Q20 Update: Lots to Like Under the Hood
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
A Differentiated EphA2-Targeted, Bicycle MMAE-Toxin Conjugate Boosted by a Potential Companion Diagnostic
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D